http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103159828-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-097 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2011-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103159828-B |
| titleOfInvention | 1-(4-hydroxy-3-methoxycarbonyl)-beta-carboline-3-formyl tryptophyl amino acid benzyl ester, and synthesis and application thereof |
| abstract | The invention discloses 16 pseudopeptides represented by a general formula I (in the general formula I, AA is equal to L-Ala, Gly, L-Leu, L-Ile, L-Val, L-Phe, L-Asp, L-Glu, L-Ser,L-Thr, L-Asn, L-Trp, L-Tyr, L-Met, L-Pro and Lys residue) and further discloses a preparation method and application thereof. The pseudopeptides show excellent in-vitro and in-vivo anti-tumor effects in a cell model and an S180 tumor-bearing mouse model and an excellent anti-inflammatory effect in a mouse ear swelling model. |
| priorityDate | 2011-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 88.